116 related articles for article (PubMed ID: 23736016)
1. S100P enhances the chemosensitivity of human gastric cancer cell lines.
Zhao X; Bai Z; Wu P; Zhang Z
Cancer Biomark; 2013; 13(1):1-10. PubMed ID: 23736016
[TBL] [Abstract][Full Text] [Related]
2. [Impact of S100P expression on clinical outcomes of gastric cancer patients with adjuvant chemotherapy of oxaliplatin and its mechanisms].
Zhao XM; Bai ZG; Ma XM; Zhang ZT; Shi XY
Zhonghua Wai Ke Za Zhi; 2010 Jul; 48(13):1004-8. PubMed ID: 21054985
[TBL] [Abstract][Full Text] [Related]
3. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
Tozawa K; Oshima T; Kobayashi T; Yamamoto N; Hayashi C; Matsumoto T; Miwa H
Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
[TBL] [Abstract][Full Text] [Related]
5. S100P contributes to chemosensitivity of human ovarian cancer cell line OVCAR3.
He Z; Gao J; Wang Q; Liu M; Li Y; Li X; Tang H; Zheng J
Oncol Rep; 2008 Aug; 20(2):325-32. PubMed ID: 18636193
[TBL] [Abstract][Full Text] [Related]
6. S100P predicts prognosis and drug resistance in gastric cancer.
Ge F; Wang C; Wang W; Wu B
Int J Biol Markers; 2013 Dec; 28(4):e387-92. PubMed ID: 23722300
[TBL] [Abstract][Full Text] [Related]
7. S100P sensitizes ovarian cancer cells to carboplatin and paclitaxel in vitro.
Wang Q; He Z; Gao J; Hu S; Huang M; Liu M; Zheng J; Tang H
Cancer Lett; 2008 Dec; 272(2):277-84. PubMed ID: 18762368
[TBL] [Abstract][Full Text] [Related]
8. [Reversal of multidrug resistance of gastric cancer cells by down-regulation of CIAPIN1 with CIAPIN1 siRNA].
Li X; Fan R; Zou X; Hong L; Gao L; Jin H; Du R; He L; Xia L; Fan D
Mol Biol (Mosk); 2008; 42(1):102-9. PubMed ID: 18389626
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Vav3 could reverse the drug resistance of gastric cancer cells by downregulating JNK signaling pathway.
Tan B; Li Y; Zhao Q; Fan L; Liu Y; Wang D; Zhao X
Cancer Gene Ther; 2014 Dec; 21(12):526-31. PubMed ID: 25430880
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
11. [Exploration on the increased sensitivity to docetaxel and reversing mechanism of drug resistance of antisense survivin RNA in gastric cancer cell line SGC7901 cells].
Ma R; Chen XH; Zhang QF; Zhu L; Tang LP; Wang J; Cheng HY; Lei LN
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):89-92. PubMed ID: 17645838
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of calcium-related genes in gastric cancer cells transfected with cellular prion protein.
Liang J; Luo G; Ning X; Shi Y; Zhai H; Sun S; Jin H; Liu Z; Zhang F; Lu Y; Zhao Y; Chen X; Zhang H; Guo X; Wu K; Fan D
Biochem Cell Biol; 2007 Jun; 85(3):375-83. PubMed ID: 17612632
[TBL] [Abstract][Full Text] [Related]
13. GSTP1 determines cis-platinum cytotoxicity in gastric adenocarcinoma MGC803 cells: regulation by promoter methylation and extracellular regulated kinase signaling.
Zhang Y; Qu X; Jing W; Hu X; Yang X; Hou K; Teng Y; Zhang J; Liu Y
Anticancer Drugs; 2009 Mar; 20(3):208-14. PubMed ID: 19396019
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of sorcin results in multidrug resistance in gastric cancer cells with up-regulation of P-gp.
He Q; Zhang G; Hou D; Leng A; Xu M; Peng J; Liu T
Oncol Rep; 2011 Jan; 25(1):237-43. PubMed ID: 21109982
[TBL] [Abstract][Full Text] [Related]
15. Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.
Shi H; Lu D; Shu Y; Shi W; Lu S; Wang K
Cancer Invest; 2008 May; 26(4):344-51. PubMed ID: 18443954
[TBL] [Abstract][Full Text] [Related]
16. The effect of TRAIL on the expression of multidrug resistant genes MDR1, LRP and GST-π in drug-resistant gastric cancer cell SGC7901/VCR.
Zhang KG; Qin CY; Wang HQ; Wang JX; Wang QM
Hepatogastroenterology; 2012; 59(120):2672-6. PubMed ID: 23178631
[TBL] [Abstract][Full Text] [Related]
17. Reduced drug accumulation is more important in acquired resistance against oxaliplatin than against cisplatin in isogenic colon cancer cells.
Ekblad L; Kjellström J; Johnsson A
Anticancer Drugs; 2010 Jun; 21(5):523-31. PubMed ID: 20168208
[TBL] [Abstract][Full Text] [Related]
18. Hypoxia-inducible factor-1 alpha contributes to hypoxia-induced chemoresistance in gastric cancer.
Liu L; Ning X; Sun L; Zhang H; Shi Y; Guo C; Han S; Liu J; Sun S; Han Z; Wu K; Fan D
Cancer Sci; 2008 Jan; 99(1):121-8. PubMed ID: 17953712
[TBL] [Abstract][Full Text] [Related]
19. Synergistic antitumor effects of dasatinib and oxaliplatin in gastric cancer cells.
Shi M; Lou B; Ji J; Shi H; Zhou C; Yu Y; Liu B; Zhu Z; Zhang J
Cancer Chemother Pharmacol; 2013 Jul; 72(1):35-44. PubMed ID: 23712327
[TBL] [Abstract][Full Text] [Related]
20. Induction of pancreatic cancer cell apoptosis, invasion, migration, and enhancement of chemotherapy sensitivity of gemcitabine, 5-FU, and oxaliplatin by hnRNP A2/B1 siRNA.
Gu WJ; Liu HL
Anticancer Drugs; 2013 Jul; 24(6):566-76. PubMed ID: 23525071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]